Tuesday, May 28, 2019

Aurobindo Pharma profit gets booster dose from U.S., Europe

R&D spend at 4.4% of revenue; launches 15 products in U.S.

from The Hindu - Industry http://bit.ly/2KckxjB
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)